# Pentabiocel in Pediatric IBS

> **NCT06720805** · NA · NOT_YET_RECRUITING · sponsor: **University of Roma La Sapienza** · enrollment: 56 (estimated)

## Conditions studied

- Irritable Bowel Syndrome (IBS)
- Pediatrics

## Interventions

- **DRUG:** Pentabiocel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06720805
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2024-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06720805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06720805, "Pentabiocel in Pediatric IBS". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06720805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*